Metabolism - Clinical and Experimental
Volume 45, Issue 4 , Pages 411-414, April 1996

Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation☆☆

Lipid Research Laboratory, Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OHUSA

Received 23 January 1995; accepted 28 October 1995.

Abstract 

The effect of the estrogen metabolites, 4-hydroxyestrone and 17α-dihydroequilin (metabolites of estradiol-17β and equilin, respectively), were examined for antioxidant effects on plasma and lipoprotein lipid peroxidation. Lipid peroxidation was evaluated by products of both fatty acid (thiobarbituric acid—reactive substances [TBARS]) and cholesterol (oxysterols) oxidation from lipoproteins or whole plasma. Although all estrogens significantly reduced lipid peroxidation, 4-hydroxyestrone was far more potent than either equilin or 17α-dihydroequilin in inhibiting TBARS formation in lipoproteins induced by Cu2+. Similar effects were also noted on TBARS formation in THP-l macrophages in culture. However, 17α-dihydroequilin (along with equilin) strongly inhibited oxysterol formation, whereas 4-hydroxyestrone was ineffective. These studies suggest that different estrogens might act preferentially on distinct lipid substrates in exhibiting antioxidant effects.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by Grant No. HL-50881 from the National Heart, Lung, and Blood Institute.

☆☆ Presented in abstract form at the Experimental Biology 95 Meeting, Atlanta, GA, April 9–13, 1995 (FASEB J 9:A891, 1995).

PII: S0026-0495(96)90212-7

Metabolism - Clinical and Experimental
Volume 45, Issue 4 , Pages 411-414, April 1996